Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma
- 1 May 2001
- journal article
- clinical trial
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 31 (5) , 722-730
- https://doi.org/10.1046/j.1365-2222.2001.01071.x
Abstract
Background Increased vascularity in airway mucosa is a distinctive feature of airway remodelling in asthma. While corticosteroids have proved most effective in modifying airway inflammation, the effect of inhaled corticosteroids on increased airway mucosal vascularity in asthmatics has been little studied. Objective We examined the effect of inhaled corticosteroid on airway vascularity in bronchial biopsy specimens taken from asthmatic patients. Subjects and methods We studied bronchial biopsies from 28 asthmatic patients before and after treatment with inhaled beclomethasone dipropionate (BDP) 800 µg/daily, or placebo, for 6 months in a double‐blind manner. Biopsy specimens were evaluated for number of vessels and percentage of area occupied by vessels, using computerized image analysis after staining for type IV collagen in vessel walls. Specimens were also examined for extent of collagen III in the subepithelial basement membrane. In addition, we compared asthmatic specimens with biopsy specimens taken from non‐asthmatic control subjects. Results There was a significant increase in number of vessels (P < 0.01) and percent vascularity (P < 0.001) in the submucosa of asthmatic patients compared with control subjects. After 6 months of treatment, we observed significant improvements in forced expiratory volume in 1 s (FEV1), FEV1% and airway responsiveness (P < 0.05, each) in the BDP treatment group compared with the placebo group. This was accompanied by significant decreases in both vessel number and percent vascularity in the airways of BDP‐treated patients (P < 0.05, each). We also observed a significant correlation between change in percent vascularity and change in collagen III thickness in the BDP‐treated patients (rs = 0.90, P < 0.001). Furthermore, the change in percent vascularity was inversely correlated with both FEV1 (rs = −0.49, P < 0.05) and airway responsiveness (rs = −0.36, P < 0.05). Conclusion These findings suggest that inhaled corticosteroid treatment of asthma reduced airway wall vascularity during airway remodelling.Keywords
This publication has 27 references indexed in Scilit:
- Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin‐like growth factor (IGF)‐I expression in bronchial asthmaClinical and Experimental Allergy, 1998
- Increased Vascularity of the Bronchial Mucosa in Mild AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.American Journal of Respiratory and Critical Care Medicine, 1997
- Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.American Journal of Respiratory and Critical Care Medicine, 1994
- Small Airways Dimensions in Asthma and in Chronic Obstructive Pulmonary DiseaseAmerican Review of Respiratory Disease, 1993
- Cellular Hypertrophy and Hyperplasia of Airway Smooth Muscles Underlying Bronchial Asthma: A 3-D Morphometric StudyAmerican Review of Respiratory Disease, 1993
- Bronchial Biopsies in Asthma: An Ultrastructural, Quantitative Study and Correlation with HyperreactivityAmerican Review of Respiratory Disease, 1989
- SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICSThe Lancet, 1989
- Mechanism by which methylprednisolone inhibits acute immune complex-induced changes in vascular permeabilityInflammation, 1986
- THE PATHOLOGY OF ASTHMA, WITH SPECIAL REFERENCE TO CHANGES IN THE BRONCHIAL MUCOSAJournal of Clinical Pathology, 1960